Try our beta test site
3 studies found for:    Insmed AND NTM
Show Display Options
Rank Status Study
1 Enrolling by invitation Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212
Condition: NTM Lung Infection Due to MAC
Intervention: Drug: Liposomal Amikacin for Inhalation
2 Active, not recruiting Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
Condition: Mycobacterium Infections, Nontuberculous
Intervention: Drug: Liposomal Amikacin for Inhalation
3 Completed Arikayce for Nontuberculous Mycobacteria
Condition: Mycobacterium Infections, Nontuberculous
Interventions: Drug: Liposomal amikacin for inhalation (LAI);   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.